Hypertension and hormone-related neoplasms in women

Hypertension

Volumn 34, Issue 2, 1999, Pages 320-325

  Soler, Maria ^a   Chatenoud, Liliane ^a   Negri, Eva ^a   Parazzini, Fabio ^a,b   Franceschi, Silvia ^c   La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Breast neoplasms; Case control studies; Endometrial neoplasms; Hypertension, essential; Ovarian neoplasms; Thyroid neoplasms

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CARCINOMA;

EID: 0032858330     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.2.320     Document Type: Article

References (47)

1. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High bloodpressure: a risk factor for cancer mortality? Lancet. 1975;1:1051-1056.
2. Raynor WR Jr, Shekelle RB, Rossof AH, Maliza C, Paul O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol. 1981;113:371-377.
3. Khaw KT, Barrett-Connor E. Systolic blood-pressure and cancer mortality in an elderly population. Am J Epidemiol. 1984;120:550-558.
4. Goldbourt U, Holtzman E, Yaari S, Cohen L, Katz L, Neufeld HN. Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10.000 middle-aged and elderly men. J Natl Cancer Inst. 1986;77:63-70.
5. Wannamethee G, Shaper AG. Blood pressure and cancer in the middle-aged British men. Int J Epidemiol. 1996;25:22-31.
6. Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, Schwartz PE, O'Connor T, White C. A case-control study of cancer of the endometrium. Am J Epidemiol. 1982;116:333-342.
7. Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer. 1990;26:781-785.
8. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer. 1997;75:1699-1703.
9. de Waard F, Baanders-van Halewijn EA. A prospective study in general practice on breast-cancer risk in menopausal women. Int J Cancer. 1974;14:153-160.
10. Moseson M, Koenig KL, Shore RE, Pasternack BS The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol. 1993;22:1000-1009.
11. Armstrong B, Stevens N, Doll R. Retrospective study of the association between use of rauwolfia derivates and breast cancer in English women. Lancet. 1974;2:672-675.
12. Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet. 1974;2:675-677.
13. Stanford JL, Martin EJ, Brinton LA, Hoover RN. Rauwolfia use and breast cancer: a case-control study. J Natl Cancer Inst. 1986;76:817-822.
14. Laska EM, Siegel C, Meisner M, Fischer S, Wanderung J. Matched-pairs study of reserpine use and breast cancer. Lancet. 1975;2:296-300.
15. Aromaa A, Hakama M, Hakulinen T, Saxén E, Teppo L, Idänpään-Heikkilä J. Breast cancer and use of rauwolfia and other anti-hypertensive agents in hypertensive patients: a nationwide case-control study in Finland. Int J Cancer. 1976;18:727-738.
16. O'Fallon WM, Labarthe DR, Kurland LT. Rauwolfia derivates and breast cancer: a case-control study in Olmstedt County, Minnesota. Lancet. 1975;2:292-296.
17. Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975;292:1366-1371.
18. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, Decarli A. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer. 1997;75:441-444.
19. Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59:1055-1060.
20. Hoogerland DL, Buchler DA, Crowley JJ, Carr WF. Estrogen use: risk of endometrial carcinoma. Gynecol Oncol. 1978;6:451-458.
21. Jelovsek FR, Hammond CB, Woodard BH, Draffin R, Lee KL, Creasman WT, Parker RT. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980;137:85-91.
22. Schwartz Z, Dgani R, Flugelman MY, Lancet M, Gelerenter I. A novel approach to the analysis of risk factors in endometrial carcinoma. Gynecol Oncol. 1985;21:228-234.
23. Tyler CW Jr, Webster LA, Ory HW, Rubin GL. Endometrial cancer: how does cigarette smoking influence the risk of women under age 55 years having this tumor? Am J Obstet Gynecol. 1985;151:899-905.
24. Franks AL, Kendrick JS, Tyler CW Jr. The Cancer and Steroid Hormone Study Group: postmenopausal smoking, estrogen replacement therapy, and the risk of endometrial cancer. Am J Obstet Gvnecol. 1987;156: 20-23.
25. Ewertz M, Schou G, Boice JD Jr. The joint effect of risk factors on endometrial cancer. Eur J Cancer Clin Oncol. 1988;24:189-194.
26. Parazzini F, Negri E, La Vecchia C, Bruzzi P, Decarli A. Population attributable risk for endometrial cancer in Northern Italy. Eur J Cancer Clin Oncol. 1989;25:1451-1456.
27. Parazzini F, La Vecchia S, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol. 1991;41:1-10.
28. Rubin GL, Peterson HB, Lee NC, Maes EF, Wingo PA, Becker S. Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. Am J Obstet Gynecol. 1990;162:148-154.
29. Parazzini F, Franceschi S, La Vecchia C, Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol. 1991;43:9-23.
30. Garfinkel L. Overweight and cancer. Ann Intern Med. 1985;103: 1034-1036.
31. Goodman MT, Kolonel LN, Wilkens LR. The association of body size, reproductive factors and thyroid cancer. Br J Cancer. 1992;66: 1180-1184.
32. Preston-Martin S, Jin F, Duda MJ, Mack WJ. A case-control study of thyroid cancer in women under age 55 in Shangai (People's Republic of China). Cancer Causes Control. 1993;4:431-440.
33. Chatenoud L, Tavani A, La Vecchia C, Jacobs DR, Negri E, Levi F, Franceschi S. Whole grain food intake and cancer risk. Int J Cancer. 1998;77:24-28.
34. Breslow EN, Day EN. Statistical Methods in Cancer Research. Vol 1. Lyon, France: IARC; 1980. IARC Scientific Publication 32.
35. McCarron DA. Diet and blood pressure: the paradigm shift. Science. 1998;281:933-934.
36. Negri E, La Vecchia C, Franceschi S, D'Avanzo B, Parazzini F. Vegetable and fruit consumption and cancer risk. Int J Cancer. 1991;48: 350-354.
37. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36-41.
38. Lipworth L. Epidemiolgy of breast cancer. Eur J Cancer Prev. 1995; 4:7-30.
39. Kelly JP, Rosenberg L, Kaufman DW, Shapiro S. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol. 1990;131:79-90.
40. Pagano R, La Vecchia C. Overweight and obesity in Italy, 1990-1991. Int J Obes. 1994;18:665-669.
41. Hamet P. Cancer and hypertension: an unresolved issues. Hypertension. 1996;28:321-324.
42. Hamet P. Cancer and hypertension: a potential for crosstalk? J Hypertens. 1997;15:1573-1577.
43. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995; 6:164-179.
44. Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol. 1998;179:6-12.
45. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami H-O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer. 1997;76:1115-1118.
46. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45:277-282.
47. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467-470.